1 Next Generation Cancer Diagnostic Devices Market Overview
1.1 Product Overview and Scope of Next Generation Cancer Diagnostic Devices
1.2 Next Generation Cancer Diagnostic Devices Segment by Type
1.2.1 Global Next Generation Cancer Diagnostic Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.2.7 Reverse Transcriptase-PCR (RT-PCR)
1.3 Next Generation Cancer Diagnostic Devices Segment by Application
1.3.1 Next Generation Cancer Diagnostic Devices Sales Comparison by Application: (2021-2027)
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Global Next Generation Cancer Diagnostic Devices Market Size Estimates and Forecasts
1.4.1 Global Next Generation Cancer Diagnostic Devices Revenue 2016-2027
1.4.2 Global Next Generation Cancer Diagnostic Devices Sales 2016-2027
1.4.3 Next Generation Cancer Diagnostic Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Next Generation Cancer Diagnostic Devices Market Competition by Manufacturers
2.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Next Generation Cancer Diagnostic Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites, Area Served, Product Type
2.5 Next Generation Cancer Diagnostic Devices Market Competitive Situation and Trends
2.5.1 Next Generation Cancer Diagnostic Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Next Generation Cancer Diagnostic Devices Players Market Share by Revenue
2.5.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Next Generation Cancer Diagnostic Devices Retrospective Market Scenario by Region
3.1 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.3.1 North America Next Generation Cancer Diagnostic Devices Sales by Country
3.3.2 North America Next Generation Cancer Diagnostic Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.4.1 Europe Next Generation Cancer Diagnostic Devices Sales by Country
3.4.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Next Generation Cancer Diagnostic Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Next Generation Cancer Diagnostic Devices Sales by Region
3.5.2 Asia Pacific Next Generation Cancer Diagnostic Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.6.1 Latin America Next Generation Cancer Diagnostic Devices Sales by Country
3.6.2 Latin America Next Generation Cancer Diagnostic Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Sales by Country
3.7.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Next Generation Cancer Diagnostic Devices Historic Market Analysis by Type
4.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
4.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2016-2021)
4.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2021)
5 Global Next Generation Cancer Diagnostic Devices Historic Market Analysis by Application
5.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
5.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2016-2021)
5.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche Holding Ltd.?Switzerland)
6.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
6.1.2 Roche Holding Ltd.?Switzerland) Description and Business Overview
6.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Holding Ltd.?Switzerland) Product Portfolio
6.1.5 Roche Holding Ltd.?Switzerland) Recent Developments/Updates
6.2 Abbott Laboratories(US)
6.2.1 Abbott Laboratories(US) Corporation Information
6.2.2 Abbott Laboratories(US) Description and Business Overview
6.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Abbott Laboratories(US) Product Portfolio
6.2.5 Abbott Laboratories(US) Recent Developments/Updates
6.3 Siemens Healthcare(Germany)
6.3.1 Siemens Healthcare(Germany) Corporation Information
6.3.2 Siemens Healthcare(Germany) Description and Business Overview
6.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Siemens Healthcare(Germany) Product Portfolio
6.3.5 Siemens Healthcare(Germany) Recent Developments/Updates
6.4 Agilent Technologies Inc(Germany)
6.4.1 Agilent Technologies Inc(Germany) Corporation Information
6.4.2 Agilent Technologies Inc(Germany) Description and Business Overview
6.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Agilent Technologies Inc(Germany) Product Portfolio
6.4.5 Agilent Technologies Inc(Germany) Recent Developments/Updates
6.5 Illumina Inc.(US)
6.5.1 Illumina Inc.(US) Corporation Information
6.5.2 Illumina Inc.(US) Description and Business Overview
6.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Illumina Inc.(US) Product Portfolio
6.5.5 Illumina Inc.(US) Recent Developments/Updates
6.6 Becton Dickinson and Co.(US)
6.6.1 Becton Dickinson and Co.(US) Corporation Information
6.6.2 Becton Dickinson and Co.(US) Description and Business Overview
6.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Becton Dickinson and Co.(US) Product Portfolio
6.6.5 Becton Dickinson and Co.(US) Recent Developments/Updates
6.7 QIAGEN N.V.(Germany)
6.6.1 QIAGEN N.V.(Germany) Corporation Information
6.6.2 QIAGEN N.V.(Germany) Description and Business Overview
6.6.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 QIAGEN N.V.(Germany) Product Portfolio
6.7.5 QIAGEN N.V.(Germany) Recent Developments/Updates
6.8 Affymetrix Inc.(US)
6.8.1 Affymetrix Inc.(US) Corporation Information
6.8.2 Affymetrix Inc.(US) Description and Business Overview
6.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Affymetrix Inc.(US) Product Portfolio
6.8.5 Affymetrix Inc.(US) Recent Developments/Updates
6.9 Johnson & Johnson(US)
6.9.1 Johnson & Johnson(US) Corporation Information
6.9.2 Johnson & Johnson(US) Description and Business Overview
6.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Johnson & Johnson(US) Product Portfolio
6.9.5 Johnson & Johnson(US) Recent Developments/Updates
6.10 Thermo Fisher Scientific Inc.(US)
6.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
6.10.2 Thermo Fisher Scientific Inc.(US) Description and Business Overview
6.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Thermo Fisher Scientific Inc.(US) Product Portfolio
6.10.5 Thermo Fisher Scientific Inc.(US) Recent Developments/Updates
6.11 GE Healthcare(England)
6.11.1 GE Healthcare(England) Corporation Information
6.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GE Healthcare(England) Product Portfolio
6.11.5 GE Healthcare(England) Recent Developments/Updates
6.12 Life Technologies Corp.(US)
6.12.1 Life Technologies Corp.(US) Corporation Information
6.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Life Technologies Corp.(US) Product Portfolio
6.12.5 Life Technologies Corp.(US) Recent Developments/Updates
6.13 Luminex Corp.(US)
6.13.1 Luminex Corp.(US) Corporation Information
6.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Luminex Corp.(US) Product Portfolio
6.13.5 Luminex Corp.(US) Recent Developments/Updates
6.14 Cepheid Inc.(US)
6.14.1 Cepheid Inc.(US) Corporation Information
6.14.2 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Cepheid Inc.(US) Product Portfolio
6.14.5 Cepheid Inc.(US) Recent Developments/Updates
6.15 Allegro Diagnostics Corp.(Brazil)
6.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
6.15.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Description and Business Overview
6.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Allegro Diagnostics Corp.(Brazil) Product Portfolio
6.15.5 Allegro Diagnostics Corp.(Brazil) Recent Developments/Updates
7 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis
7.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
7.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Next Generation Cancer Diagnostic Devices Distributors List
8.3 Next Generation Cancer Diagnostic Devices Customers
9 Next Generation Cancer Diagnostic Devices Market Dynamics
9.1 Next Generation Cancer Diagnostic Devices Industry Trends
9.2 Next Generation Cancer Diagnostic Devices Growth Drivers
9.3 Next Generation Cancer Diagnostic Devices Market Challenges
9.4 Next Generation Cancer Diagnostic Devices Market Restraints
10 Global Market Forecast
10.1 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Next Generation Cancer Diagnostic Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Type (2022-2027)
10.2 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Next Generation Cancer Diagnostic Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Application (2022-2027)
10.3 Next Generation Cancer Diagnostic Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Next Generation Cancer Diagnostic Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
